HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.

AbstractBACKGROUND AND AIMS:
Exercise may enhance the effect of alendronate on bone mineral density (BMD) and reduce chronic back pain in elderly women with osteoporosis. The aim of this study was to determine whether whole-body vibration exercise would enhance the effect of alendronate on lumbar BMD and bone turnover, and reduce chronic back pain in postmenopausal women with osteoporosis.
METHODS:
Fifty post-menopausal women with osteoporosis, 55-88 years of age, were randomly divided into two groups of 25 patients each: one taking alendronate (5 mg daily, ALN) and one taking alendronate plus exercise (ALN+EX). Exercise consisted of whole-body vibration using a Galileo machine (Novotec, Pforzheim, Germany), at an intensity of 20 Hz, frequency once a week, and duration of exercise 4 minutes. The study lasted 12 months. Lumbar BMD was measured by dual energy X-ray absorptiometry (Hologic QDR 1500W). Urinary cross-linked N-terminal telopeptides of type I collagen (NTX) and serum alkaline phosphatase (ALP) levels were measured by enzyme-linked immunosorbent assay and standard laboratory techniques, respectively. Chronic back pain was evaluated by face scale score at baseline and every 6 months.
RESULTS:
There were no significant differences in baseline characteristics, including age, body mass index, years since menopause, lumbar BMD, urinary NTX and serum ALP levels, or face scale score between the two groups. The increase in lumbar BMD and the reduction in urinary NTX and serum ALP levels were similar in the ALN and ALN+EX groups. However, the reduction in chronic back pain was greater in the ALN+EX group than in the ALN group.
CONCLUSIONS:
The results of this study suggest that whole-body vibration exercise using a Galileo machine appears to be useful in reducing chronic back pain, probably by relaxing the back muscles in post-menopausal osteoporotic women treated with alendronate.
AuthorsJun Iwamoto, Tsuyoshi Takeda, Yoshihiro Sato, Mitsuyoshi Uzawa
JournalAging clinical and experimental research (Aging Clin Exp Res) Vol. 17 Issue 2 Pg. 157-63 (Apr 2005) ISSN: 1594-0667 [Print] Italy
PMID15977465 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Phosphorus
  • Alkaline Phosphatase
  • Calcium
  • Alendronate
Topics
  • Accidental Falls (statistics & numerical data)
  • Aged
  • Aged, 80 and over
  • Alendronate (therapeutic use)
  • Alkaline Phosphatase (blood)
  • Back Pain (prevention & control)
  • Bone Density (drug effects)
  • Bone Remodeling (drug effects)
  • Calcium (blood)
  • Chronic Disease
  • Exercise
  • Female
  • Humans
  • Lumbar Vertebrae
  • Middle Aged
  • Osteoporosis, Postmenopausal (drug therapy)
  • Phosphorus (blood)
  • Vibration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: